Kwality Pharmac Standalone June 2024 Net Sales at Rs 80.08 crore, up 18.72% Y-o-Y
August 13, 2024 / 12:07 IST
Reported Standalone quarterly numbers for Kwality Pharmaceuticals are:Net Sales at Rs 80.08 crore in June 2024 up 18.72% from Rs. 67.45 crore in June 2023.
Quarterly Net Profit at Rs. 8.37 crore in June 2024 up 53.65% from Rs. 5.45 crore in June 2023.
EBITDA stands at Rs. 17.64 crore in June 2024 up 24.23% from Rs. 14.20 crore in June 2023.
Kwality Pharmac EPS has increased to Rs. 8.06 in June 2024 from Rs. 5.17 in June 2023.
| Kwality Pharmac shares closed at 589.85 on August 12, 2024 (BSE) and has given 29.65% returns over the last 6 months and 50.20% over the last 12 months. |
| Kwality Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 80.08 | 91.98 | 67.45 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 80.08 | 91.98 | 67.45 | | EXPENDITURE | | Consumption of Raw Materials | 37.43 | 47.73 | 33.48 | | Purchase of Traded Goods | 2.77 | -- | 0.10 | | Increase/Decrease in Stocks | -1.18 | -1.70 | -0.53 | | Power & Fuel | -- | -- | -- | | Employees Cost | 9.72 | 8.98 | 7.62 | | Depreciation | 4.02 | 5.04 | 4.78 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 13.99 | 16.10 | 12.97 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 13.34 | 15.82 | 9.03 | | Other Income | 0.28 | 0.58 | 0.40 | | P/L Before Int., Excpt. Items & Tax | 13.62 | 16.40 | 9.42 | | Interest | 2.48 | 3.06 | 2.19 | | P/L Before Exceptional Items & Tax | 11.14 | 13.34 | 7.24 | | Exceptional Items | -- | -7.10 | -- | | P/L Before Tax | 11.14 | 6.24 | 7.24 | | Tax | 2.77 | 1.75 | 1.79 | | P/L After Tax from Ordinary Activities | 8.37 | 4.50 | 5.45 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 8.37 | 4.50 | 5.45 | | Equity Share Capital | 10.38 | 10.38 | 10.38 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 8.06 | 4.33 | 5.17 | | Diluted EPS | 8.06 | 4.33 | 5.17 | | EPS After Extra Ordinary | | Basic EPS | 8.06 | 4.33 | 5.17 | | Diluted EPS | 8.06 | 4.33 | 5.17 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
